Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Paper
  • Published:

Phosphorylation of cyclin D1 at Thr 286 during S phase leads to its proteasomal degradation and allows efficient DNA synthesis

Abstract

Continuing proliferation requires regulation of cyclin D1 levels in each cell cycle phase. Growth factors stimulate high levels during G2 phase, which commits the cell to continue through G1 phase with sufficient cyclin D1 to initiate DNA synthesis. Upon entry into S phase, however, cyclin D1 levels rapidly decline. Our goal is to understand the mechanism and importance of this S-phase suppression. Here, we demonstrate that cyclin D1 levels decline during S phase due to reduced protein stability, without alterations in the rate of protein synthesis. This decline depends upon Thr 286, since mutation of this site eliminates the normal pattern of cyclin D1 suppression during S phase. As evidence that phosphorylation of Thr 286 is responsible for this decline, Thr 286 is shown to be more efficiently phosphorylated during S phase than in other cell cycle periods. Finally, high cyclin D1 levels during S phase are shown to inhibit DNA synthesis. This inhibitory activity presumably blocks the growth of cells with altered cyclin D1 expression characteristics. Abnormal stimulation of cyclin D1 might result in levels high enough to promote G1/S phase transition even in the absence of appropriate growth stimuli. In such cells, however, the levels of cyclin D1 would presumably be too high to be suppressed during S phase, resulting in the inhibition of DNA synthesis.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6
Figure 7
Figure 8
Figure 9
Figure 10

Similar content being viewed by others

Abbreviations

GSK3:

glycogen synthase kinase 3

PI-3 kinase:

phosphatidylinositol-3 kinase

Rb:

retinoblastoma

GFP:

green fluorescent protein

CDK:

cyclin-dependent kinase

References

  • Aktas H, Cai H and Cooper GM . (1997). Mol. Cell. Biol., 17, 3850–3857.

  • Alt JR, Cleveland JL, Hannink M and Diehl JA . (2000). Genes Dev., 14, 3102–3114.

  • Atadja P, Wong H, Veillete C and Riabowol K . (1995). Exp. Cell Res., 217, 205–216.

  • Bagui TK, Mohapatra S, Haura E and Pledger WJ . (2003). Mol. Cell. Biol., 23, 7285–7290.

  • Baldin V, Lukas J, Marcote MJ, Pagano M and Draetta G . (1993). Genes Dev., 7, 812–821.

  • D'Amico M, Hulit J, Amanatullah DF, Zafonte BT, Albanese C, Bouzahzah B, Fu M, Augenlicht LH, Donehower LA, Takemaru K, Moon RT, Davis R, Lisanti MP, Shtutman M, Zhurinsky J, Ben-Ze'ev A, Troussard AA, Dedhar S and Pestell RG . (2000). J. Biol. Chem., 275, 32649–32657.

  • Diehl JA, Cheng M, Roussel MF and Sherr CJ . (1998). Genes Dev., 12, 3499–3511.

  • Fukami-Kobayashi J and Mitsui Y . (1999). Exp. Cell Res., 246, 338–347.

  • Guo Y, Stacey DW and Hitomi M . (2002). Oncogene, 21, 7545–7556.

  • Han EK, Begemann M, Sgambato A, Soh JW, Doki Y, Xing WQ, Liu W and Weinstein IB . (1996). Cell Growth Differ., 7, 699–710.

  • Hitomi M and Stacey DW . (1999a). Curr. Biol., 9, 1075–1084.

  • Hitomi M and Stacey WD . (1999b). Mol. Cell. Biol., 19, 4423–4432.

  • Kelly BL, Wolfe KG and Roberts JM . (1998). Proc. Natl. Acad. Sci. USA, 95, 2535–2540.

  • Lukas J, Pagano M, Staskova Z, Draetta G and Bartek J . (1994). Oncogene, 9, 707–718.

  • Matsuoka S, Yamaguchi M and Matsukage A . (1994). J. Biol. Chem., 269, 11030–11036.

  • Matsushime H, Roussel MF, Ashmun RA and Sherr CJ . (1991). Cell, 65, 701–713.

  • Mittnacht S . (1998). Curr. Opin. Genet. Dev., 8, 21–27.

  • Pagano M, Theodoras AM, Tam SW, Draetta GF and Chen J . (1994). Genes Dev., 8, 1627–1639.

  • Sa G, Hitomi M, Harwalkar J, Stacey AW, Chen G and Stacey DW . (2002). Cell Cycle, 1, 50–58.

  • Sa G and Stacey DW . (2004). Exp. Cell Res., 300, 427–439.

  • Scovassi AI, Stivala LA, Rossi L, Bianchi L and Prosperi E . (1997). Exp. Cell Res., 237, 127–134.

  • Sewing A, Burger C, Brusselbach S, Schalk C, Lucibello FC and Muller R . (1993). J. Cell Sci., 104, 545–555.

  • Sherr CJ and Roberts JM . (1995). Genes Dev., 9, 1149–1163.

  • Solomon DA, Wang Y, Fox SR, Lambeck TC, Giesting S, Lan Z, Senderowicz AM and Knudsen ES . (2003). J. Biol. Chem., 278, 30339–30347.

  • Stacey DW . (2003). Curr. Opin. Cell Biol., 15, 158–163.

  • Woodgett JR . (2001). Sci. STKE (Electronic Resource): Signal Transduction Knowledge Environment, 2001, RE12.

  • Xiong Y, Zhang H and Beach D . (1992). Cell, 71, 505–514.

Download references

Acknowledgements

We thank Gaurisankar Sa for helpful suggestions throughout these studies. This work was supported by Grants CA9219 and GM52271 from the National Institutes of Health.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Dennis W Stacey.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Guo, Y., Yang, K., Harwalkar, J. et al. Phosphorylation of cyclin D1 at Thr 286 during S phase leads to its proteasomal degradation and allows efficient DNA synthesis. Oncogene 24, 2599–2612 (2005). https://doi.org/10.1038/sj.onc.1208326

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1208326

Keywords

This article is cited by

Search

Quick links